Inside Impurities: Ask the Expert

Impurities management is evolving. Is your strategy keeping pace?

We’re launching Inside Impurities: Ask the Expert - a new expert-led series exploring the regulatory, analytical and practical challenges shaping pharmaceutical impurity management.

We begin with two conversations on Impurities:

EPISODE 1 | 18 November

Navigating the Evolving Regulatory Landscape in India

With Dr. Arvind Kumar Sharma, Scientific Officer, Indian Pharmacopoeia Commission, and Dr. Kuldeep Sharma, Agilent.

EPISODE 2 | 25 November

Beyond Small Molecules: Impurities Challenges in Next-Generation Biotherapeutics

With Dr. Sanjib Banerjee, COO, Veeda Lifesciences, and Ashish Pargaonkar, Agilent.

From regulatory expectations and risk assessment to Impurities, advanced analytics and emerging risks in biotherapeutics, these conversations address questions teams are facing today.

Submit your questions. Get expert solutions.